s.vukovic

TL2 · Dijon

Contributes reviews on supplier material. Based in Dijon.

Joined 23 March 2025 · last posted 5d

93 posts, newest first. Showing up to 150.

Alcohol: what is documented and what is folklore Replied, post #128 · Practice › Interactions · 23 Jul 2026 · 6 likes Alcohol has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
A critique that turned out to be unfair, retracted by its author Replied, post #35 · Evidence › Study critique · 21 Jul 2026 · 12 likes Practical answer on critique, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
Deletion sequences: expected mass shifts by residue — the long version Replied, post #9 · Analytics › Impurities & related substances · 12 Jul 2026 · 0 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #90 · Start Here › Welcome · 9 Jul 2026 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #94 · Devices › Syringes & needles · 4 Jul 2026 · 30 likes Answering the question post #90 raises rather than the one it answers. On 0.3 ml versus 0.5 ml I would separate what is worth knowing from what is worth acting on. The…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #61 · Evidence › Journal club · 26 Jun 2026 · 10 likes I read the earlier replies on SURMOUNT-OSA twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #11 · Lounge › Off topic · 21 Jun 2026 · 9 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
Fasting versus non-fasting and which tests care Replied, post #52 · Clinical › Bloodwork · 20 Jun 2026 · 7 likes Everything in post #48 holds. The case it does not cover is the one I have. Repeat before acting is standard practice for an isolated abnormal result on most analytes,…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #87 · Practice › Reconstitution · 17 Jun 2026 · 0 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
Racemisation and why it is invisible to a mass measurement Replied, post #54 · Analytics › Impurities & related substances · 11 Jun 2026 · 2 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #19 · Documentation › Doc review · 7 Jun 2026 · 0 likes Since draft on reconstitution arithmetic keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #83 · Evidence › Journal club · 5 Jun 2026 · 15 likes I had written a reply contradicting post #79 and deleted it. Here is what survived. Orforglipron phase 2 has a well-known answer and a correct answer, and the…
Revisiting: Absolute versus relative contraindications Replied, post #78 · Safety › Contraindications · 29 Apr 2026 · 9 likes Where the Absolute versus relative contraindications discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
Amylin receptor signalling and satiety — what changed since Replied, post #68 · Pharmacology › Receptor biology · 25 Apr 2026 · 3 likes Post #66 describes the usual case. This is about the unusual one. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #64 · Outcomes › Body composition · 24 Apr 2026 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #17 · Wellbeing › Sleep · 19 Apr 2026 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
Reading U-100 graduations, with a conversion table Replied, post #21 · Devices › Syringes & needles · 12 Apr 2026 · 19 likes Reading the barrel at eye level matters more than any equipment choice. Parallax at a shallow angle is enough to shift a reading by a graduation.
[2026 update] What a purity-only report leaves out Replied, post #79 · Sourcing › Independent verification · 5 Apr 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
What a certificate commits its issuer to — one year on Replied, post #41 · Analytics › COA interpretation · 31 Mar 2026 · 1 like Post #40 answers the question as asked. The question underneath it is different. An itemised related-substances table with retention times says considerably more about…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #39 · Analytics › Mass spectrometry · 29 Mar 2026 · 19 likes That is the distinction I keep failing to hold on to. Written down now.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #109 · Pharmacology › Pharmacokinetics · 18 Mar 2026 · 24 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #3 · Practice › Administration · 8 Mar 2026 · 0 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
CJC-1295 with and without DAC: what the modification does Replied, post #8 · Compounds › Secretagogues & GH axis · 5 Mar 2026 · 6 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #3 · Practice › Administration · 24 Feb 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Someone…
Pharmacy supply in the UK and the questions you will be asked Replied, post #52 · Regional › UK & Ireland · 23 Feb 2026 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed. That…
How the published trials escalated, tabulated side by side Replied, post #7 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Micro-titration: a disputed topic, argued properly Replied, post #35 · Practice › Dosing & titration · 16 Feb 2026 · 31 likes This follows post #32 rather than contradicting it. Two people in this thread mean different things by micro-titration and are disagreeing about the definition while…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #9 · Compounds › Repair & healing peptides · 12 Feb 2026 · 0 likes Post #6 is the version of this I will quote in future. One addition. Dose-response is unstudied in humans for essentially everything in this family, which means the…
Filter needles: when they help and what they cost you Replied, post #45 · Devices › Syringes & needles · 5 Feb 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
Trifluoroacetate content and its consequences Replied, post #71 · Analytics › Impurities & related substances · 3 Feb 2026 · 21 likes Picking up post #70: that is the part I would want checked first. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide.…
Why the titration planner refuses to produce a schedule below a floor Replied, post #33 · Data & Tools › Calculators · 28 Jan 2026 · 1 like I read post #29 twice before replying, because I had assumed the opposite. Posting my titration planner refuses numbers with the method attached so they can be…
A partial dose because the pen emptied mid-injection Replied, post #24 · Practice › Administration · 7 Jan 2026 · 2 likes Right, and stated more narrowly than I would have dared to state it.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #13 · Documentation › Wiki requests · 27 Dec 2025 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. That is the version I use. It may not be…
Comparing my trajectory with the trial curves, carefully Replied, post #93 · Outcomes › Progress reports · 20 Dec 2025 · 7 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. That is the shape of it. The detail is…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #24 · Analytics › Method validation · 10 Dec 2025 · 0 likes Narrowing post #23, because the general version has more than one answer. Inter-laboratory comparison is a good example of a question where the honest answer is boring…
[2026 update] What steady state means for the decision to escalate Replied, post #134 · Practice › Dosing & titration · 18 Nov 2025 · 15 likes I would keep steady state and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
Gauge and length selection for subcutaneous injection Replied, post #51 · Devices › Syringes & needles · 16 Nov 2025 · 1 like Post #50 is the version of this I will quote in future. One addition. The claim about gauge and length selection upthread is stronger than its source supports. I have…
Freeze-thaw and why one cycle is not the same as five Replied, post #17 · Practice › Storage & stability · 31 Oct 2025 · 4 likes Answering the question post #15 raises rather than the one it answers. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
New subcategory: rationale and scope Replied, post #92 · Meta › Announcements · 22 Oct 2025 · 13 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable.
Validating a method you did not develop Replied, post #4 · Analytics › Method validation · 22 Oct 2025 · 0 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. It is a small point and it…
New subcategory: rationale and scope Replied, post #73 · Meta › Announcements · 20 Oct 2025 · 3 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. That is the practical version. The rigorous version is…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #41 · Start Here › Welcome · 16 Oct 2025 · 1 like Agreed, and I will stop repeating the version of this I had been repeating.
Compounds this community declines to help with, and why Replied, post #17 · Compounds › Other compounds · 26 Sep 2025 · 28 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #31 · Evidence › Study critique · 13 Sep 2025 · 18 likes Adding the measurement that post #28 says would settle it. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you…
[2026 update] Splitting an overlong document into two Replied, post #31 · Documentation › Wiki requests · 9 Sep 2025 · 32 likes The question underneath Splitting an overlong document is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #95 · Compounds › Oral incretins · 4 Sep 2025 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Dose equivalence between oral and injectable formulations is not a simple…
Enforcement priorities versus written rules — does this still hold? Replied, post #35 · Sourcing › Regulatory · 29 Aug 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #44 · Evidence › Journal club · 16 Aug 2025 · 0 likes Post #42 and I disagree about the size of the effect, not about the direction. Sessions on negative or null results are consistently the most instructive and the…
Are there stupid questions here? A staff answer, at length Replied, post #77 · Start Here › Welcome · 16 Aug 2025 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #39 · Sourcing › Vendor reports · 13 Aug 2025 · 7 likes Coming back to post #36, because the follow-up matters more than the original answer. On vendor documentation pages the community has more anecdote than the confidence…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #24 · Practice › Dosing & titration · 11 Aug 2025 · 13 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #44 · Compounds › Secretagogues & GH axis · 7 Aug 2025 · 31 likes This is the sort of exchange that makes the archive worth searching.
A ten-fold dose error caught before injection — one year on Replied, post #43 · Devices › Syringes & needles · 2 Aug 2025 · 19 likes One caution on ten-fold dose error caught: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
Coming back to: When "no data" is the complete and final answer Replied, post #66 · Compounds › Other compounds · 31 Jul 2025 · 27 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #10 · Wellbeing › Mental health · 27 Jul 2025 · 4 likes Picking up post #9: that is the part I would want checked first. I would be cautious about generalising from the Anxiety example above. It is a good example. It is one…
Angle of injection and whether 90 degrees is always right Replied, post #4 · Practice › Administration · 25 Jul 2025 · 0 likes One more thing on angle of injection that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
Trust level 3 requirements: a clarification Replied, post #2 · Meta › Announcements · 21 Jul 2025 · 14 likes Taking the opening post at face value and following it one step further. Thank you for announcing it in advance rather than after. The number of places that do the…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #35 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 3 likes For anyone finding this later: the short answer on Area percent versus weight percent is that it depends on one thing, and the rest of the thread is people identifying…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #159 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 0 likes On post #157 — agreed on the reasoning, with one qualification. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
A supplier that answers analytical questions with restated claims Replied, post #95 · Sourcing › Red flags · 12 Jun 2025 · 24 likes Nobody has said the unglamorous part of supplier yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #37 · Devices › Cold chain · 10 Jun 2025 · 3 likes Thank you — that answers what I came here to find out.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #66 · Wellbeing › Mental health · 8 Jun 2025 · 10 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 4 Jun 2025 · 2 likes Post #14 is the version of this I will quote in future. One addition. Published human data on cagrilintide alone is thinner than on the combination, which is the…
Pregnancy as an absolute contraindication Replied, post #35 · Safety › Contraindications · 18 May 2025 · 24 likes Building on post #33 rather than restating it. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning…
Reading a trial's population section before its results — does this still hold? Replied, post #103 · Evidence › Trials · 14 May 2025 · 5 likes Narrowing post #100, because the general version has more than one answer. A treatment-policy estimand asks what happens to people assigned to a strategy, including…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #5 · Analytics › COA interpretation · 14 May 2025 · 0 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. The distinction between release testing and characterisation is one industrial…
A well-designed study with a badly written abstract Replied, post #78 · Evidence › Study critique · 12 May 2025 · 3 likes Confirming post #75 from a second method, which matters more than confirming it from a second person. Hold a trial to the standard something could actually have met. A…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #102 · Devices › Cold chain · 12 May 2025 · 21 likes Answering the question post #100 raises rather than the one it answers. Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a…
About the Datasets category Replied, post #4 · Data & Tools › Datasets · 6 Apr 2025 · 22 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #14 · Compounds › Retatrutide · 3 Apr 2025 · 0 likes Post #10 and I disagree about the size of the effect, not about the direction. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
Journal club: SURMOUNT-1, read without the press release Replied, post #84 · Evidence › Journal club · 25 Mar 2025 · 9 likes Genuine question rather than a rhetorical one: has anyone here actually observed SURMOUNT-1, as opposed to read about it? The thread is long and I cannot tell.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #125 · Sourcing › Vendor reports · 18 Mar 2025 · 6 likes Post #123 is right about the mechanism and I think understates the practical bit. Pattern across lots: a single result is a data point. Three or four results from the…
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #14 · Analytics › Impurities & related substances · 17 Feb 2025 · 19 likes Reading back through the Attributing a new peak threads from last year, the same three questions come up every time and only one of them has ever been answered…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #5 · Analytics › Mass spectrometry · 6 Feb 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Resolution and mass accuracy are different specifications. An instrument can resolve two species…
Oxidation and deamidation mass shifts, tabulated Replied, post #46 · Analytics › Mass spectrometry · 1 Feb 2025 · 1 like Coming back to post #42, because the follow-up matters more than the original answer. Combining a chromatographic result with a mass result is genuinely orthogonal…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #101 · Evidence › Journal club · 22 Jan 2025 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
[2026 update] New subcategory: rationale and scope Replied, post #108 · Meta › Announcements · 31 Dec 2024 · 0 likes On post #104 — agreed on the reasoning, with one qualification. On New subcategory I would separate what is worth knowing from what is worth acting on. The first list…
What would change my mind about repair peptides: a specific answer — one year on Replied, post #14 · Compounds › Repair & healing peptides · 23 Dec 2024 · 20 likes Answering the question post #12 raises rather than the one it answers. Reported local reactions are common enough in first-hand accounts here to be worth mentioning and…
Building a sensible monitoring schedule with your prescriber Replied, post #15 · Clinical › Bloodwork · 18 Dec 2024 · 0 likes A methods point on building a sensible monitoring schedule rather than a substantive one: if the comparison is not like for like, the difference you are measuring is…
[2026 update] New subcategory: rationale and scope Replied, post #74 · Meta › Announcements · 18 Dec 2024 · 12 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #94 · Analytics › Method validation · 14 Dec 2024 · 13 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
Asking about a compound your prescriber has not heard of — one year on Replied, post #11 · Clinical › Prescriber conversations · 3 Dec 2024 · 3 likes Worth separating two things that post #7 runs together. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring…
Second pass at: How to research a compound with no human data without deceiving yourself Started this topic · Compounds › Other compounds · 22 Nov 2024 · 20 likes Second pass at: How to research a compound with no human data without deceiving yourself Writing it up because I had to work it out twice and would rather nobody else…
EMA product information as a primary source — does this still hold? Replied, post #129 · Regional › European Union · 18 Nov 2024 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #20 · Access › Insurance & coverage · 9 Nov 2024 · 10 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #2 · Evidence › Journal club · 21 Oct 2024 · 1 like The arithmetic in the opening post is right; the assumption feeding it is the part to check. The most common failure mode is spending fifty minutes on the effect size…
Requesting a page: what makes a good request — what changed since Replied, post #117 · Documentation › Wiki requests · 13 Oct 2024 · 4 likes Post #116 is the version of this I will quote in future. One addition. Flag a page that has drifted: if you notice a maintained page has information that is outdated…
Requesting a page: what makes a good request — what changed since Replied, post #98 · Documentation › Wiki requests · 12 Oct 2024 · 20 likes The arithmetic in post #97 is right; the assumption feeding it is the part to check. Correction requests: if you spot an error in a maintained page, note it here with…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #133 · Nutrition & Training › Hydration & electrolytes · 4 Oct 2024 · 12 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
A page that has drifted out of date and needs a maintainer Replied, post #3 · Documentation › Wiki requests · 17 Aug 2024 · 0 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. The step people skip is the one I have spelled out.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 7 Jul 2024 · 13 likes Post #21 is the version of this I will quote in future. One addition. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you…
Cold packs, phase-change material, and what survives ten days Replied, post #65 · Sourcing › Logistics · 3 Jul 2024 · 18 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive…
Follow-up: Dead volume across syringe and needle combinations Replied, post #3 · Devices › Syringes & needles · 23 Jun 2024 · 8 likes The opening post describes the usual case. This is about the unusual one. Safety-engineered needles are worth using if you have children or anyone else in the house,…